Evidence map›Paper›PMID 38771379›Full record

ArticleEJNMMI research2024

Radiation dosimetry of para-chloro-2-[

Isabella Silins, Adrian Moreno, Anders Wall, Franklin Aigbirhio, Mark Gurnell, Morris Brown, Sara Roslin, Gunnar Antoni, Per Hellman, Anders Sundin and 1 more

Registry-linked trialAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in EJNMMI research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05361083 (Studies of 18F-CETO as a Tracer for Adrenal PET Diagnostics), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05361083 early_phase1completednot on this map

Studies of 18F-CETO as a Tracer for Adrenal PET Diagnostics

TypeinterventionalSponsorUppsala UniversityRan2019 to 2022Enrolled20ConditionsPrimary Aldosteronism Due to Aldosterone Producing Adenoma, Primary Aldosteronism Due to Nodular Hyperplasia, Adrenal Cushing Syndrome, Non-Secretory Adrenal AdenomaArmsF18CETO
3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Isabella SilinsDepartment of Surgical Sciences, Uppsala University, Uppsala, SE-751 85, Sweden.
Adrian MorenoDepartment of Surgical Sciences, Uppsala University, Uppsala, SE-751 85, Sweden.
Anders WallDepartment of Surgical Sciences, Uppsala University, Uppsala, SE-751 85, Sweden.
Franklin AigbirhioWolfson Brain Imaging Centre, University of Cambridge, Cambridge, UK.
Mark GurnellInstitute of Metabolic Science & Department of Medicine, University of Cambridge, Cambridge, UK.
Morris BrownWilliam Harvey Heart Centre, Queen Mary University of London, London, UK.
Sara RoslinDepartment of Medicinal Chemistry, Uppsala University, Uppsala, Sweden.
Gunnar AntoniDepartment of Medicinal Chemistry, Uppsala University, Uppsala, Sweden.
Per HellmanDepartment of Surgical Sciences, Uppsala University, Uppsala, SE-751 85, Sweden.
Anders Sundin *Department of Surgical Sciences, Uppsala University, Uppsala, SE-751 85, Sweden.
Mark Lubberink *Department of Surgical Sciences, Uppsala University, Uppsala, SE-751 85, Sweden. mark.lubberink@uu.se.ORCID http://orcid.org/0000-0001-8324-7399

Funding

Medical Research Council MR/P01710X/1
6 · The paper itself

Abstract

background[

results[

conclusions[

trial registrationClinicalTrials.gov, NCT05361083 Retrospectively registered 29 April 2022. at, URL: https://clinicaltrials.gov/ct2/show/NCT05361083.

Indexed as

[18F]CETOAdenomaAdrenalConn adenomaPositron emission tomographyPrimary aldosteronismTumour

Identifiers

PMID38771379
PMCPMC11109037

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.